✦ LIBER ✦

Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age versus those <75 years of age

✍ Scribed by Ioannis Iakovou; George Dangas; Roxana Mehran; Gary S Mintz; Alexandra J Lansky; Eve D Aymong; Eugenia Nikolsky; Tudor Vagaonescu; Lynne A Glasser; Gregg W Stone; Martin B Leon; Jeffrey W Moses

Book ID: 113440452
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 84 KB
Volume: 92
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2003.07.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of effect of glycoprotein IIb

Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age vs. those <75 years of age

✍ I. Iakovou; G. Dangas; R. Mehran 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Comparison of frequency of hemorrhagic s

Comparison of frequency of hemorrhagic stroke in patients <75 years versus ≥75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions

✍ Ioannis Iakovou; George Dangas; Gary S. Mintz; Roxana Mehran; Alexandra J. Lansk 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Comparison of One-Year Outcome of Patien

Comparison of One-Year Outcome of Patients Aged <75 Years Versus ≥75 Years Undergoing “Rescue” Percutaneous Coronary Intervention

✍ Francesco De Felice; Rosario Fiorilli; Antonio Parma; Carmine Musto; Marco Stefa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Comparison of six-month outcomes of perc

Comparison of six-month outcomes of percutaneous transluminal coronary angioplasty in patients ≥75 with those <75 years of age (the ROSETTA registry)

✍ Haim A Abenhaim; Mark J Eisenberg; David Schechter; Jeffrey Lefkovits; Evelyne G 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Comparison of effectiveness and safety o

Comparison of effectiveness and safety of simvastatin in patients <75 versus ≥75 years of age with coronary, cerebral, or peripheral arterial disease

✍ Jennifer G Robinson; Cynthia Conroy; William J Wickemeyer 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Comparison of Outcomes in High-Risk Pati

Comparison of Outcomes in High-Risk Patients >70 Years of Age With Aortic Valvuloplasty and Percutaneous Coronary Intervention Versus Aortic Valvuloplasty Alone

✍ Wes R. Pedersen; Paul J. Klaassen; Christopher W. Pedersen; Jessica A. Wilson; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB